Numis Corporation (LSE: NUM)

Last close As at 16/04/2024

GBP3.43

0.00 (0.00%)

Market capitalisation

GBP402m

Numis is one of the UK’s leading independent corporate advisory and stockbroking groups, offering a full range of research, execution, equity capital markets, corporate broking and advisory services. It employs over 270 staff in offices in London and New York, and at the end of September 2018 had 210 corporate clients.

Latest Insights

View More
Numis-Corporation_resized

Sector

Financials

Balance Sheet

Forecast net debt (£m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
% 1M 3M 12M
Actual 0.3 3.0 89.3
Relative 4.7 9.4 85.6
52 week high/low 343.0p/170.6p

Financials

Edison Investment Research is terminating coverage on Kinarus Therapeutics (KNRS), Numis Corporation (NUM), EMIS Group (EMIS), Pixium Vision (PIX) and Treatt (TET). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Previously published reports can still be accessed via website

Y/E Sep Revenue (£m) EBITDA (£m) PBT (£m) EPS (fd) (p) P/E (x) P/CF (x)
2021A 215.6 72.3 74.2 49.1 7.0 N/A
2022A 144.2 25.6 20.9 11.9 28.8 N/A
2023E N/A N/A N/A N/A N/A N/A
2024E N/A N/A N/A N/A N/A N/A

Thematics

thematic

Financials

South African life assurers: Where is the growth?

thematic

Financials

IFRS 17: Impact on life assurance companies

thematic

Financials

Crypto, are you dead yet?

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free